Brain damage markers in children. Neurobiological and clinical aspects

Acta Paediatrica, International Journal of Paediatrics

Volumn 91, Issue 1, 2002, Pages 9-13

  Leviton, Alan ^a   Dammann, O ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Brain damage; Children

Indexed keywords

BIOCHEMICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

BLOOD ANALYSIS; BRAIN CELL; BRAIN INJURY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HIGH RISK POPULATION; HUMAN; MEASUREMENT; NEUROBIOLOGY; NEWBORN SCREENING; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; VALIDATION PROCESS;

BIOLOGICAL MARKERS; BRAIN DAMAGE, CHRONIC; BRAIN INJURIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 0036177308     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/080352502753457851     Document Type: Review

References (64)

1. Serum S-100 protein levels after pediatric cardiac operations: A possible new marker for postperfusion cerebral injury
2. Release of the cerebral protein s-100 into blood after reperfusion during cardiac operations in infants: Is there a relation to oxygen radical-induced lipid peroxidation?
3. Cytokine and S 100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest
4. S-100 after correction of congenital heart defects in neonates: Is it a reliable marker for cerebral damage?
5. Increased levels of S-100 protein after cardiac surgery with cardiopulmonary bypass and general surgery in children
6. Elevated S 100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry
7. Serum immunoreactivity to S-100 in children with cerebral palsy and delayed development and in their healthy parents
8. Evaluation of protein S-100 serum concentrations in healthy newborns and seven newborns with perinatal acidosis
9. Brain specific proteins in posthaemorrhagic ventricular dilatation
10. Serum S 100 protein: A potential marker for cerebral events during cardiopulmonary bypass
11. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: A possible marker for cerebral injury
12. Serum markers of brain damage and outcome prediction in patients after severe head injury
13. Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery
14. Do blood levels of neuron-specific enolase and S-100 protein reflect cognitive dysfunction after coronary artery bypass?
15. Serum S 100 protein as a marker of cerebral damage during cardiac surgery
16. Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery
17. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein
18. Measurement of S-100 protein in human blood and cerebrospinal fluid: Analytical method and preliminary clinical results
19. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage
20. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke
21. A contrastive analysis of release patterns of biochemical markers of brain damage after coronary artery bypass grafting and valve replacement and their association with the neurobehavioral outcome after cardiac surgery
22. Neurobehavioral outcome prediction after cardiac surgery: Role of neurobiochemical markers of damage to neuronal and glial brain tissue
23. Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF
24. Biochemical markers in acute ischemic stroke
25. Spermidine: A predictor for neurological outcome and infarct size in focal cerebral ischemia?
26. S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction
27. Functional roles of S 100 proteins, calcium-binding proteins of the EF-hand type
28. Validation and comparison of two solid-phase immunoassays for the quantification of S-100B in human blood
29. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)
30. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells
31. Expression of two neuronal markers, growth-associated protein 43 and neuron-specific enolase, in rat glial cells
32. Influence of hemolysis on the measurement of S-100beta protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting
33. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia
34. The S 100 protein family: History, function, and expression
35. Expression pattern of S 100 calcium-binding proteins in human tumors
36. Prognostic value of serum analyses of S-100beta protein in malignant melanoma
37. Neuron specific enolase in small cell lung cancer. Clinical and biochemical evaluation
38. Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: A pilot study
39. Serum S-100B protein in severe head injury
40. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood
41. Serum S-100 protein release and neuropsychologic outcome during coronary revascularization on the beating heart: A prospective randomized study
42. S-100ao protein in blood and urine during open-heart surgery
43. Leakage of brain-originated proteins in peripheral blood: Temporal profile and diagnostic value in early ischemic stroke
44. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography
45. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage
46. Serum S-100 protein, relationship to clinical outcome in acute stroke
47. Neuronal and glial apoptosis after traumatic spinal cord injury
48. Cellular and molecular mechanisms of glial scarring and progressive cavitation: In vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma
49. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury
50. Gene encoding the beta subunit of S 100 protein is on chromosome 21: Implications for Down syndrome
51. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome
52. Life-long overexpression of S 100beta in Down's syndrome: Implications for Alzheimer pathogenesis
53. Enhancement of S-100beta protein in blood of patients with Down's syndrome
54. The S 100 family of EF-hand calcium-binding proteins: Functions and pathology
55. S 100beta induces neuronal cell death through nitric oxide release from astrocytes
56. S 100B, a neurotropic protein that modulates neuronal protein phosphorylation, is upregulated during lesion-induced collateral sprouting and reactive synaptogenesis
57. Differential expression of S 100beta and glial fibrillary acidic protein in the hippocampus after kainic acid-induced lesions and mossy fiber sprouting in adult rat
58. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702
59. Differential expression of S 100B and S 100A6(1) in the human fetal and aged cerebral cortex
60. The development of the human blood-CSF-brain barrier
61. S 100B protein concentrations in cord blood: Correlations with gestational age in term and preterm deliveries
62. Measurement of glial fibrillary acidic protein in human blood: Analytical method and preliminary clinical results
63. Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke
64. Role of the fetus in perinatal infection and neonatal brain damage